Profound Medical (NASDAQ:PROF) reported quarterly losses of $(0.27) per share which missed the analyst consensus estimate of $(0.26) by 3.85 percent. This is a 35 percent decrease over losses of $(0.20) per share from the same period last year. The company reported quarterly sales of $5.977 million which missed the analyst consensus estimate of $7.233 million by 17.37 percent. This is a 43.09 percent increase over sales of $4.177 million the same period last year.